Smith G M, Boon R J, Beale A S
Beecham Pharmaceuticals Research Division, Betchworth, Surrey, England.
Antimicrob Agents Chemother. 1990 Feb;34(2):210-4. doi: 10.1128/AAC.34.2.210.
An experimental respiratory infection caused by Streptococcus pneumoniae was established in weanling rats by intrabronchial instillation. Treatment of this infection with amoxicillin rapidly eliminated the pneumococci from the lung tissue. A beta-lactamase-producing strain of Staphylococcus aureus, when inoculated in a similar manner, did not persist adequately in the lungs long enough to permit a reasonable assessment of the therapy, but staphylococcal survival was extended in the lungs of rats infected 24 h previously with S. pneumoniae. Amoxicillin therapy was relatively ineffective against the pneumococci in this polymicrobial infection and had no effect on the growth of S. aureus. In contrast, amoxicillin-clavulanic acid eliminated the pneumococci from the lung tissue and brought about a reduction in the numbers of staphylococci. The data illustrate the utility of this model for the study of polymicrobial lung infections and demonstrate the role of amoxicillin-clavulanic acid in the treatment of polymicrobial infections involving beta-lactamase-producing bacteria.
通过支气管内滴注法在断奶大鼠中建立了由肺炎链球菌引起的实验性呼吸道感染。用阿莫西林治疗这种感染可迅速从肺组织中清除肺炎球菌。以类似方式接种的产β-内酰胺酶的金黄色葡萄球菌菌株在肺中不能充分持续存在足够长的时间以进行合理的治疗评估,但在24小时前感染肺炎链球菌的大鼠肺中,葡萄球菌的存活时间延长。在这种混合感染中,阿莫西林治疗对肺炎球菌相对无效,并且对金黄色葡萄球菌的生长没有影响。相比之下,阿莫西林-克拉维酸可从肺组织中清除肺炎球菌,并使葡萄球菌数量减少。这些数据说明了该模型在研究混合性肺部感染中的实用性,并证明了阿莫西林-克拉维酸在治疗涉及产β-内酰胺酶细菌的混合感染中的作用。